KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Cash & Current Investments: 2018-2025

Historic Cash & Current Investments for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $232.4 million.

  • Twist Bioscience's Cash & Current Investments fell 15.90% to $232.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 13.59%. This contributed to the annual value of $232.4 million for FY2025, which is 15.90% down from last year.
  • As of Q3 2025, Twist Bioscience's Cash & Current Investments stood at $232.4 million, which was down 7.33% from $250.8 million recorded in Q2 2025.
  • Twist Bioscience's 5-year Cash & Current Investments high stood at $573.9 million for Q1 2022, and its period low was $232.4 million during Q3 2025.
  • Moreover, its 3-year median value for Cash & Current Investments was $289.4 million (2024), whereas its average is $296.6 million.
  • Over the last 5 years, Twist Bioscience's Cash & Current Investments had its largest YoY gain of 141.52% in 2021, and its largest YoY loss of 48.60% in 2021.
  • Quarterly analysis of 5 years shows Twist Bioscience's Cash & Current Investments stood at $301.9 million in 2021, then skyrocketed by 45.34% to $438.7 million in 2022, then decreased by 29.08% to $311.1 million in 2023, then dropped by 12.96% to $270.8 million in 2024, then declined by 15.90% to $232.4 million in 2025.
  • Its last three reported values are $232.4 million in Q3 2025, $250.8 million for Q2 2025, and $257.1 million during Q1 2025.